These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9741839)

  • 1. Plasma disappearance of exogenous erythropoietin in mice under different experimental conditions.
    Lezón CE; Martínez MP; Conti MI; Bozzini CE
    Endocrine; 1998 Jun; 8(3):331-3. PubMed ID: 9741839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of stimulated erythropoietin production in mice with enhanced erythropoiesis.
    Lezón C; Alippi RM; Barceló AC; Martínez MP; Conti MI; Bozzini CE
    Haematologica; 1995; 80(6):491-4. PubMed ID: 8647512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected hypoxia-dependent erythropoietin secretion during experimental conditions not affecting tissue oxygen supply/demand ratio.
    Bozzini CE; Barceló AC; Conti MI; Martínez MP; Lezón CE; Bozzini C; Alippi RM
    Kidney Int; 1997 Feb; 51(2):413-5. PubMed ID: 9027714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced hypoxia-stimulated erythropoietin production in mice with depression of erythropoiesis induced by hyperoxia.
    Bozzini CE; Barceló AC; Conti MI; Martínez MP; Alippi RM
    High Alt Med Biol; 2003; 4(1):73-9. PubMed ID: 12713714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin.
    Misaizu T; Matsuki S; Strickland TW; Takeuchi M; Kobata A; Takasaki S
    Blood; 1995 Dec; 86(11):4097-104. PubMed ID: 7492766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher erythropoietin secretion in response to cobaltous chloride in post-hypoxic than in hypertransfused polycythemic mice.
    Alippi RM; Boyer P; Leal T; Barcelò AC; Martinez MP; Bozzini CE
    Haematologica; 1992; 77(6):446-9. PubMed ID: 1289180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced effect of increased erythrocyte production rate on plasma erythropoietin levels of mice during subsequent exposure to hypobaria.
    Bozzini CE; Alippi RM; Barcelo AC
    Adv Exp Med Biol; 1989; 271():23-7. PubMed ID: 2486286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Erythropoietin Response to Acute Hypoxemia in Mice with Pharmacological Depression of Erythropoiesis.
    Martínez MP; Conti MI; Lezón CE; Alippi RM; Bozzini CE
    Hematology; 1996; 1(3):247-52. PubMed ID: 27406619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
    Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
    Jensen JD; Jensen LW; Madsen JK; Poulsen L
    Eur J Haematol; 1995 Feb; 54(2):111-6. PubMed ID: 7698293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.
    Jelkmann W
    Eur J Haematol; 2002; 69(5-6):265-74. PubMed ID: 12460230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin requirement for the maintenance of normal levels of erythropoiesis in the normal adult mouse.
    Barrio Rendo ME
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(4):225-8. PubMed ID: 9504182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery.
    McCluskey SA; Cheung WK; Katznelson R; Poonawala H; Fedorko L; Djaiani G; Mehta B; Karkouti K
    Eur J Clin Pharmacol; 2009 Mar; 65(3):273-9. PubMed ID: 18972109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology and clinical applications of recombinant erythropoietin.
    Spivak JL
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):7-11. PubMed ID: 9671323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of pure human erythropoietin in the rat.
    Emmanouel DS; Goldwasser E; Katz AI
    Am J Physiol; 1984 Jul; 247(1 Pt 2):F168-76. PubMed ID: 6742201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.